News Ambros' $125m for pain disorder drug, and other financings Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.
News Sanofi reported to be looking at an Insmed takeover Sanofi CEO Belén Garijo has said she wants to make M&A deals, and the rumour mill is now linking the French group to a possible takeover of Insmed.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.